**Question:** Advantages of ultrasound nuchal translucency over biochemical screening for Down syndrome include

**Core Concept:** Ultrasound nuchal translucency (NT) is a measurement taken during a prenatal ultrasound examination to assess the risk of chromosomal abnormalities, particularly trisomy 21 (Down syndrome). Biochemical screening involves measuring certain blood markers to assess the risk of Down syndrome.

**Why the Correct Answer is Right:** Ultrasound nuchal translucency offers several advantages over biochemical screening for Down syndrome detection:

A. **Immediate and direct assessment:** NT measurement provides a direct visualization of the fluid accumulation in the fetal neck, allowing for a more accurate assessment of the risk compared to relying on blood tests that may have varying degrees of accuracy and may not be completed until weeks later.

B. **Visualization of additional abnormalities:** Ultrasound examination can also reveal other structural or chromosomal abnormalities, allowing for a more comprehensive evaluation of fetal wellbeing.

C. **Non-invasive nature:** NT measurement is non-invasive, unlike biochemical screening that involves blood samples, reducing the risk of complications associated with invasive procedures.

D. **Faster results:** While biochemical screening may take weeks to provide results, ultrasound examination can be performed at the same visit, providing immediate risk assessment to the patient and healthcare provider.

**Why Each Wrong Option is Incorrect:**

A. **Biochemical screening limitations:** Although biochemical screening has its own limitations, such as varying sensitivity and specificity, it is still a valuable tool in assessing Down syndrome risk alongside ultrasound examination.

B. **Single test approach:** While combining both ultrasound nuchal translucency and biochemical screening can enhance the overall risk assessment, relying solely on one test (either ultrasound or biochemical) is also valid in certain clinical contexts.

C. **Invasive nature of biochemical screening:** Although biochemical screening involves a small needle stick, it is not exclusively invasive. Both ultrasound and biochemical screening have their respective invasiveness.

D. **Slow results delivery:** While biochemical screening may result in slower information delivery, ultrasound examination can still provide valuable insights into fetal wellbeing, including nuchal translucency assessment.

**Clinical Pearl:** Ultrasound nuchal translucency screening is crucial for early detection of chromosomal abnormalities like Down syndrome. This non-invasive procedure, when combined with biochemical screening, can provide a more comprehensive assessment of the fetus's health and wellbeing during prenatal care.